OrganOx metra System
Organox Limited · Decision date Oct 9, 2026
What did the FDA approve?
The FDA record for P200035/S038, dated 2026-10-09, lists a supplement to the OrganOx metra System PMA under the normal 180-day track, with the reason given as a change to design, components, specifications or materials. The reported changes cover a new supplier of the Blood Reservoir, minor manufacturing process changes for the filter materials, and increased wall thickness of five tubing segments in the blood circulation loop of Disposable Set D0146/D0146-US. The record does not quantify any of these changes or describe their verification.
The P200035 identifier ties this supplement to the existing PMA rather than to a separate approval, and the decision field reads APPR. The device category is described as a normothermic machine perfusion system for donor livers before transplantation. The supplied fields do not give test data, inspection findings or performance results, so the decision is a regulatory action on the described changes and not independent evidence of safety or clinical effectiveness.
The specific information absent is the basis for the decision beyond the listed change categories: no review memo, testing summary or closure rationale is included in these fields.
FDA approval order statement
changing the supplier of the Blood Reservoir, minor manufacturing process changes for the filter materials, and increasing the wall thickness of the five (5) tubing segments in the blood circulation loop of Disposable Set (D0146/D0146-US)
- Regulatory pathway
- PMA supplement
- Supplement type
- Normal 180 Day Track
- Clinical specialty
- Gastroenterology, Urology
- Decision date
- Oct 9, 2026
- FDA change category
- Change Design/Components/Specifications/Material
FDA source record · MedtechLedger’s explanation describes the recorded change.
Regulatory record facts
- Identifier
- P200035/S038
- Regulatory pathway
- PMA supplement
- Applicant
- Organox Limited
- Product code
- QQK
- Decision code
- APPR
- Decision date
- Oct 9, 2026
- Source update
- Nov 9, 2026
- Original record
- Open FDA source record
About this medical device
FDA device category: Normothermic machine perfusion system for the preservation of donor livers prior to transplantation.
- Applicant
- Organox Limited
- Product code
- QQK
- FDA device class
- 3
For the original device and its historical approval scope, see PMA P200035. Subsequent supplements may change the device or its indications.
FDA decision timeline
P200035 · Original PMA
OrganOx metra System
P200035/S038 received
Application receipt date recorded by FDA.
P200035/S038 · FDA decision
Normal 180 Day Track
Timeline entries are records held by MedtechLedger for P200035. View FDA’s full supplement list.
Related devices and submissions
Same PMA: P200035
| Product / regulatory record | Company | Pathway | Decision date | Source |
|---|---|---|---|---|
OrganOx metra SystemP200035 | Organox Limited | PMA approval | Dec 9, 2021 | FDA |
Regulatory context
A PMA supplement records a change to a device with an existing premarket approval. The supplement’s approval applies to the change described in that submission.
Read our guide to FDA clearance and approval · FDA’s explanation of this pathway
Manufacturer intelligence
Organox Limited
- Headquarters
- Not reported
- Brand website
- Not reported
- FDA applicant address
- Oxford Science Park, Magdalen Centre, Robert Robinson Ave., Oxford, OX4 4GA
Sources and methodology
- Original FDA record: P200035/S038
- openFDA source data · Source release Nov 9, 2026 · Retrieved Nov 19, 2026
FDA fields and approval-order wording are presented as source information. MedtechLedger explanations are identified separately and describe the scope of the recorded decision. Indications from an original PMA are historical unless confirmed against subsequent labeling and supplements.
How we use FDA records